所有图片(2)
选择尺寸
变更视图
25 MG
¥815.23
100 MG
¥2,744.98
About This Item
经验公式（希尔记法）:
Mo
CAS Number:
分子量:
95.94
MDL编号:
UNSPSC代码:
12141727
PubChem化学物质编号:
NACRES:
NA.23
推荐产品
方案
≥99.9%
表单
foil
制造商/商品名称
Goodfellow 884-221-27
电阻率
5.0 μΩ-cm, 20°C
沸点
4612 °C (lit.)
mp
2617 °C (lit.)
密度
10.3 g/mL at 25 °C (lit.)
SMILES字符串
[Mo]
InChI
1S/Mo
InChI key
ZOKXTWBITQBERF-UHFFFAOYSA-N
1 of 4
此商品 | 76183 | PHR1455 | Y0000800 |
|---|---|---|---|
| biological source synthetic | biological source synthetic | biological source - | biological source synthetic |
| assay 95.0-100.5% | assay ≥99.0% (RT) | assay - | assay - |
| form powder | form powder | form - | form solid |
| application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| Quality Level 200 | Quality Level 200 | Quality Level 300 | Quality Level - |
| color light yellow | color white to faint yellow | color - | color - |
一般描述
For updated SDS information please visit www.goodfellow.com.
法律信息
Product of Goodfellow
John R Guyton et al.
Journal of the American College of Cardiology, 62(17), 1580-1584 (2013-08-07)
This study sought to examine the relationship between niacin treatment, lipoproteins, and cardiovascular (CV) outcomes in this secondary analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes) trial. During a
Koon K Teo et al.
Stroke, 44(10), 2688-2693 (2013-07-25)
In Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcomes (AIM-HIGH) trial, addition of extended-release niacin (ERN) to simvastatin in participants with established cardiovascular disease, low high-density lipoprotein cholesterol, and high triglycerides had no incremental
Paul M Lavigne et al.
Journal of the American College of Cardiology, 61(4), 440-446 (2012-12-26)
This study sought to assess the efficacy of niacin for reducing cardiovascular disease (CVD) events, as indicated by the aggregate body of clinical trial evidence including data from the recently published AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High
Beat Müller et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 20(2), 181-195 (2003-10-11)
A novel methodology for establishing a pharmacological dose-effect relationship of methyl nicotinate, hexyl nicotinate and nicotinic acid acting as peripheral vasodilators in the skin following topical application is investigated. This methodology involves the estimation of the unbound drug concentration in
Martina Lukasova et al.
Trends in pharmacological sciences, 32(12), 700-707 (2011-09-29)
Nicotinic acid (niacin) has been used for decades to prevent and treat atherosclerosis. The well-documented antiatherogenic activity is believed to result from its antidyslipidemic effects, which are accompanied by unwanted effects, especially a flush. There has been renewed interest in
商品
Humankind has utilized protein materials throughout its existence, starting with the use of materials such as wool and silk for warmth and protection from the elements and continuing with the use of recombinant DNA techniques to synthesize proteins with unique and useful properties.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
